Loading…
Loading… fetching the latest figures.
Loading…
Loading… fetching the latest figures.
Elevance Health Inc is a Health Care company listed on NEW YORK STOCK EXCHANGE, INC..
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
via Wikipedia →The basics, explained simply — no finance degree required.
The lowest and highest price this stock has traded at over the past year.
How much this stock pays you back each year, just for holding it — as a % of the share price.
How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.
How much the company's sales grew compared to a year ago.
How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.
Annual figures from the company's own SEC filings. Tap any number to open the filing it came from.
| Fiscal year ending | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| RevenueGrowth = this year ÷ prior year − 1 | $199.1B+12.5% | $177.0B+3.3% | $171.3B+9.4% | $156.6B+13.0% |
| Operating incomeMargin = operating income ÷ revenue | $7.2B3.6% margin | $7.9B4.4% margin | $8.5B5.0% margin | $8.3B5.3% margin |
| Net incomeMargin = net income ÷ revenue | $5.7B2.8% margin | $6.0B3.4% margin | $6.0B3.5% margin | $5.9B3.8% margin |
| Operating cash flowCash the business generated, vs net income above | $4.3B | $5.8B | $8.1B | $8.4B |
| Cash vs long-term debtCash − long-term debt. Excludes short-term borrowings and leases | — | -$20.9B$8.3B cash · $29.2B debt | -$16.7B$6.5B cash · $23.2B debt | -$15.0B$7.4B cash · $22.3B debt |
| Shares (weighted avg.)Change = this year ÷ prior year − 1 | 224M-3.3% | 232M-1.8% | 236M-1.7% | 240M-1.6% |
Automatic checks on the figures above. A flag is a pattern to investigate, not a finding of wrongdoing, and each one lists ordinary explanations for it.
Revenue rose 12.5% in the year to Dec 2025, while operating cash flow fell 26.1%.
| Revenue | Dec 2025 | $199.1B |
| Revenue | Dec 2024 | $177.0B |
| Operating cash flow | Dec 2025 | $4.3B |
| Operating cash flow | Dec 2024 | $5.8B |
How it's calculated: Revenue change = revenue ÷ prior-year revenue − 1. Cash flow change = operating cash flow ÷ prior-year operating cash flow − 1.
Rule: Revenue up 5% or more in the latest year while operating cash flow fell 10% or more.
Why it can matter: Sales growth that isn't turning into cash can mean customers are paying more slowly, stock is building up, or revenue is being recorded well before the cash arrives.
Common innocent explanations: A large one-off tax or pension payment, the timing of customer payments around year-end, or a deliberate build-up of stock ahead of expected growth.
See every flagged company in Market Watch →
Source: SEC EDGAR annual reports (Form 10-K), latest filed 2026-02-06. If a company later restates a year, the most recent filing is used. Dashes mean the company did not report that line in a form we could read. For information only, not investment advice.
Recent notices ELVhas filed with the SEC (Form 8-K). Headings are the SEC's own item titles; open the filing to read what the company said.
A filing appearing here is not a sign of a problem: most are routine. We highlight a few kinds, such as auditor changes, listing notices and leadership changes, because they are worth reading. For information only, not investment advice.
Recent buys and sells by company executives and directors — publicly disclosed, as required by law.